A team of researchers at the University of Miami Miller School of Medicine have uncovered a potential approach for treating patients with serious long-term COVID conditions. In two recent studies using experimental models, they found that placing a peptide “net” around the spike protein on the virus reduced deaths from organ failure and improved overall outcomes.
Article title: Severe acute pancreatitis: Capillary permeability model linking systemic inflammation to multiorgan failure Authors: Nicole L. Komara, Pedram Paragomi, Phil J. Greer, Anette S. Wilson, Cameron Breze, Georgios I. Papachristou, David C. Whitcomb From the authors: “With the use of…
While the world waits eagerly for a safe and effective vaccine to prevent infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the COVID-19 pandemic, researchers also are focusing on better understanding how SARS-CoV-2 attacks the body in the search for other means of stopping its devastating impact. The key to one possibility — blocking a protein that enables the virus to turn the immune system against healthy cells — has been identified in a recent study by a team of Johns Hopkins Medicine researchers.
There’s some good news in New Jersey about a potentially deadly tick-borne bacterium. Rutgers researchers examined more than 3,000 ticks in the Garden State and found only one carrying Rickettsia rickettsii, the bacterium that causes Rocky Mountain spotted fever. But cases of tick-borne spotted fevers have increased east of the Mississippi River, and more research is needed to understand why, according to a study in the American Journal of Tropical Medicine and Hygiene.